Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOGA-guided MSC Injection in Heart Failure
NCT00644410Phase 2Completed
- Sponsor
- Rigshospitalet
- Start
- Sep 2008
- Primary completion
- Mar 2015
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in heart failure (HF) comparing Mesenchymal Stromal Cells with Placebo (2 arms). Primary endpoint: Left Ventricular End-Systolic Volume at 6 months. Started Sep 2008; status: completed.
02
Drugs
Provacel
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00644410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00644410.